LIF will provide 240.000 tablets of Amoxicillin 500 mg to the National Health Ministry.
LIF had already participated in the latest bid Nº 55/12 announced by Health Ministry to buy different medicines. On this occasion, Santa Fe’s Laboratory had the best price for this Beta-lactam tablet.
This medication will be used by Health Ministry to attend to opportunistic infections.These are infections caused by opportunistic pathogens, such as bacterial infections that usually do not cause disease in a healthy host, one with a healthy immune system.
Monday, March 4, 2013
Tuesday, February 26, 2013
Meeting at Laboratorio de Hemoderivados
LIF SE’s Directors, Carlos Arques, Guillermo Cleti and the General Manager Roberto Ganin, visited the Laboratorio de Hemoderivados (LH), in which Universidad Nacional de Córdoba (UNC) has full ownership.
LH are specialists in medicines production through plasma derivatives (products manufactured from human plasma by plasma fractionation techniques).
Also, LH produces injection medicines apart from non-plasma derivatives.
THE Directors met with the main authorities Catalina Massa (Executive Director), Ada María Sisti (Technical Director), Cristian Moya (Production Manager) and Daniel Sabena (Marketing Manager).
LIF’s staff members worked on an agreement between LIF and LH to produce some of these injections for the Health Public System of Santa Fe.
Friday, January 18, 2013
LIF will produce metformin to REMEDIAR
LIF will produce eight million tablets of Metformin 500 mg to increase the critical stock of the REMEDIAR Program of the National Health Ministry.
The Program couldn’t take the offer in the last bid announced to buy different medicines because of the expensive price the dealer offered.
Thus, LIF will deliver four million tablets in March and the rest in May 2013.
Metformin is an oral antidiabetic drug. It is the first-line drug of choice for the treatment of type 2 diabetes, in particular, in overweight and obese people and those with normal kidney function.
The Program couldn’t take the offer in the last bid announced to buy different medicines because of the expensive price the dealer offered.
Thus, LIF will deliver four million tablets in March and the rest in May 2013.
Metformin is an oral antidiabetic drug. It is the first-line drug of choice for the treatment of type 2 diabetes, in particular, in overweight and obese people and those with normal kidney function.
Thursday, November 15, 2012
AGREEMENT BETWEEN LIF AND IAPOS
Last week an agreement of “Mutual collaboration and assistance” was signed between LIF and IAPOS (Santa Fe’s social health insurance for civil servants).
The main objective is to deliver high-quality medicine at affordable prices for IAPOS and to give mutual assistance to improve healthcare, guaranteeing the efficiency and making the best use of the resources.
Background of LIF and IAPOS
In 2008, the Health Ministry of Santa Fe signed an agreement of mutual collaboration with IAPOS and Pharmacist’s College to carry out actions related to birth control, to prevent unwanted pregnancies and to reduce maternal death.
In 2009, the Health Ministry of Santa Fe started the provision of LIF contraceptives to women who were sexually active within the public health system and IAPOS coverage.
From May 2009 to date LIF has delivered 34,557 contraceptive cycles to IAPOS and 1,187,056 contraceptive cycles to the Health Ministry of Santa Fe to use in the public health system.
The main objective is to deliver high-quality medicine at affordable prices for IAPOS and to give mutual assistance to improve healthcare, guaranteeing the efficiency and making the best use of the resources.
Background of LIF and IAPOS
In 2008, the Health Ministry of Santa Fe signed an agreement of mutual collaboration with IAPOS and Pharmacist’s College to carry out actions related to birth control, to prevent unwanted pregnancies and to reduce maternal death.
In 2009, the Health Ministry of Santa Fe started the provision of LIF contraceptives to women who were sexually active within the public health system and IAPOS coverage.
From May 2009 to date LIF has delivered 34,557 contraceptive cycles to IAPOS and 1,187,056 contraceptive cycles to the Health Ministry of Santa Fe to use in the public health system.
Friday, October 19, 2012
State Production of Medicines, research and coffee
LIF Director Cleti gave the lecture together with Pharmacist Nelson Sturtz, Technical Director of the Pilot Plant of the Pharmacy School – UNR.
State production of medicines, research, scientific innovations and orphan drugs were some of the topics developed by both specialists.
This Scientific Café session took place at La Favrika Bar in Rosario and the topic was a replay of the lecture that Cleti and Sturtz gave in Santa Fe last September. This lecture is part of a program organized by Science and Technology Secretary, UNL, UCA Santa Fe and CONICET Santa Fe.
The purpose of this program is to allow the population to meet with scientists and researchers to talk about interesting topics.
Tuesday, October 9, 2012
Lecture at FEFARA
On Thursday 27, LIF Board of Directors Carlos Arques gave a presentation about state production of medications at Federal and International Meeting of Policy, Economy and Management of Medicines organized by the Federación Farmacéutica Argentina (FEFARA: the pharmaceutical federation in Argentina).
The lecture, entitled: “State Production of Medicines, the first step of a long way”, took place at Ros Tower Hotel in Rosario on September 27 and 28.
LIF Director started the presentation talking about the LIF’s experience as an example of an efficient state-run company. Then he gave information about the advances in state production in Santa Fe, its importance as a tool for the population to access medicines, the investment in the last four years and LIF’s future projects.
The lecture, entitled: “State Production of Medicines, the first step of a long way”, took place at Ros Tower Hotel in Rosario on September 27 and 28.
LIF Director started the presentation talking about the LIF’s experience as an example of an efficient state-run company. Then he gave information about the advances in state production in Santa Fe, its importance as a tool for the population to access medicines, the investment in the last four years and LIF’s future projects.
Tuesday, September 25, 2012
Term meeting of LIF’s staff members
On Thursday 20, all LIF’s staff members attended the two-hour term meeting that took place at LIF headquarters.
At the beginning, some of the topics in the meeting were the projects of future production of medicines for national programs, organizational training and the Directors’ latest activities.
It should be noted that the Social Observatory of the UNL carried out a survey last August and the staff made proposals concerning internal communication and social and work relationships at LIF. During the meeting the Board of Directors gave feedback on the proposals which had been provided in previous workshops about job satisfaction and organizational atmosphere. Finally, the meeting included a question and answer session among all present.
It should be noted that the Social Observatory of the UNL carried out a survey last August and the staff made proposals concerning internal communication and social and work relationships at LIF. During the meeting the Board of Directors gave feedback on the proposals which had been provided in previous workshops about job satisfaction and organizational atmosphere. Finally, the meeting included a question and answer session among all present.
Subscribe to:
Posts (Atom)


